Branchioskeletogenital syndrome

Branchioskeletogenital syndrome (also known as Elsahy-Waters syndrome or branchial arch syndrome) is an extremely rare genetic disorder characterized by a combination of craniofacial, skeletal, and genital abnormalities. The condition was first described by Elsahy and Waters in 1971. Key craniofacial features include a broad face, hypertelorism (widely spaced eyes), a broad or depressed nasal bridge, and abnormalities of the branchial arches. Skeletal manifestations may include brachydactyly (short fingers), short stature, and various bone anomalies. Genital abnormalities, particularly hypospadias in males, are a hallmark feature of the syndrome. Some patients may also exhibit intellectual disability or developmental delay. The syndrome primarily affects the craniofacial structures (derived from the branchial arches), the skeletal system, and the genitourinary system. Additional features that have been reported include dental anomalies, hearing impairment, and mild to moderate cognitive impairment. Given the extreme rarity of this condition, only a small number of cases have been described in the medical literature, making it difficult to fully delineate the clinical spectrum. There is currently no specific cure or targeted therapy for branchioskeletogenital syndrome. Management is supportive and symptomatic, typically involving a multidisciplinary team including craniofacial surgeons, orthopedic specialists, urologists, and developmental specialists. Surgical correction of hypospadias and craniofacial anomalies may be indicated. Developmental support and educational interventions are recommended for individuals with cognitive involvement. Genetic counseling is advised for affected families.

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Common questions about Branchioskeletogenital syndrome